drugset / Trial / NCT05877053
A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants
RandomizedParallel-groupTriple-blindBasic science
Summary
The purposes of this study are to: * Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects. * Find out how much CK-4021586 is in the blood after a single dose and multiple doses. * Determine the effect different doses of CK-4021586 on the pumping function of the heart. * Determine the effect of food in the stomach on how much CK-4021586 is in the blood after a single dose.
Timeline
- Start
- 2023-05-09
- Primary completion
- 2024-11-20
- Completion
- 2024-11-20
Outcome
Met primary endpoint
release “today announced topline data from the Phase 1 study of CK-4021586 (CK-586). The study met its primary and secondary objectives” cytokinetics.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CK-4021586 | Unknown | — | — |
Indications
No indication recorded.